Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms

ObjectiveThe COVID-19 pandemic led to unprecedented temporary federal and state regulatory flexibilities that rapidly transformed medication for opioid use disorder (MOUD) treatment delivery. This study aimed to understand changes in treatment providers' care during COVID-19, provider experiences with the adaptations, and perceptions of which changes should be sustained long-term.MethodsWe conducted in-depth, semi-structured interviews with 20...